Citations

Clear

4610 citation(s) found for "Lu, Brian".

Classic and 11-oxygenated androgens in serum and saliva across adulthood: a cross-sectional study analyzing the impact of age, body mass index, and diurnal and menstrual cycle variation
Schiffer, Lina , Kempegowda, Punith , Sitch, Alice , Shaheen, Fozia , Ebbehøj, Andreas , Singh, Sumitabh , McTaggart, Malcom P, Prete, Alessandro , Hawley, James , Keevil, Brian , Taylor, Angela E. , Arlt, Wiebke , Sitch, Alice J , Ebbehøj, Andreas Ladefoged , Prete, Alessandro , Bancos, Irina , Arlt, Wiebke , Taylor, Angela E , Adaway, Jo , McTaggart, Malcolm P. , O'Reilly, Michael W , Bancos, Irina

Mayo Clinic

European Journal of Endocrinology | January 10, 2023 | Volume: 188 | Issue: 1 | Pages: 86-100

10.1093/ejendo/lvac017 | PMID 36651154 Get It

Abstract Objective 11-oxygenated androgens significantly contribute to the circulating androgen pool. Understanding the physiological variation of 11-oxygenated androgens and their determinants is essential for clinical interpretation, for example, in androgen excess conditions. We quantified classic and 11-oxygenated androgens in serum and saliva across the adult age and body mass index (BMI) range, also analyzing diurnal and menstrual cycle-dependent variation. Design Cross-sectional. Morning serum samples were collected from 290 healthy volunteers (125 men, 22-95 years; 165 women, 21-91 years). Morning saliva samples were collected by a sub-group (51 women and 32 men). Diurnal saliva profiles were collected by 13 men. Twelve women collected diurnal saliva profiles and morning saliva samples on 7 consecutive days during both follicular and luteal menstrual cycle phases. Methods Serum and salivary steroids were quantified by liquid chromatography–tandem mass spectrometry profiling assays. Results Serum classic androgens decreased with age-adjusted BMI, for example, %change kg/m2 for 5α-dihydrotestosterone: men −5.54% (95% confidence interval (CI) −8.10 to −2.98) and women −1.62% (95%CI −3.16 to −0.08). By contrast, 11-oxygenated androgens increased with BMI, for example, %change kg/m2 for 11-ketotestosterone: men 3.05% (95%CI 0.08-6.03) and women 1.68% (95%CI −0.44 to 3.79). Conversely, classic androgens decreased with age in both men and women, while 11-oxygenated androgens did not. Salivary androgens showed a diurnal pattern in men and in the follicular phase in women; in the luteal phase, only 11-oxygenated androgens showed diurnal variation. Conclusions Classic androgens decrease while active 11-oxygenated androgens increase with increasing BMI, pointing toward the importance of adipose tissue mass for the activation of 11-oxygenated androgens. Classic but not 11-oxygenated androgens decline with age.
Environmental chemicals and endogenous metabolites in bile of USA and Norway patients with primary sclerosing cholangitis
Juran, Brian D., Ali, Ahmad H. , Schlicht, Erik M., Bianchi, Jackie K., Hu, Xin , Liang, Yongliang , Liu, Ken , Go, Young‐Mi , Folseraas, Trine , Karlsen, Tom H. , Athreya, Arjun P. , Grant, Caroline W. , Ali, Ahmad H , Go, Young-Mi , Miller, Gary W. , Lazaridis, Konstantinos N , Jarrell, Zachery Ryan , Jones, Dean P. , Walker, Douglas Ian , LaRusso, Nicholas F. , Gores, Gregory J. , Lazaridis, Konstantinos N.

Mayo Clinic

Exposome | January 8, 2023 | Volume: 3 | Issue: 1 | Pages: No page available

10.1093/exposome/osac011 | PMID 36687160 Get It

Abstract Primary sclerosing cholangitis (PSC) is a complex bile duct disorder. Its etiology is incompletely understood, but environmental chemicals likely contribute to risk. Patients with PSC have an altered bile metabolome, which may be influenced by environmental chemicals. This novel study utilized state-of-the-art high-resolution mass spectrometry (HRMS) with bile samples to provide the first characterization of environmental chemicals and metabolomics (collectively, the exposome) in PSC patients located in the United States of America (USA) (n = 24) and Norway (n = 30). First, environmental chemical- and metabolome-wide association studies were conducted to assess geographic-based similarities and differences in the bile of PSC patients. Nine environmental chemicals (false discovery rate, FDR < 0.20) and 3143 metabolic features (FDR < 0.05) differed by site. Next, pathway analysis was performed to identify metabolomic pathways that were similarly and differentially enriched by the site. Fifteen pathways were differentially enriched (P < .05) in the categories of amino acid, glycan, carbohydrate, energy, and vitamin/cofactor metabolism. Finally, chemicals and pathways were integrated to derive exposure–effect correlation networks by site. These networks demonstrate the shared and differential chemical–metabolome associations by site and highlight important pathways that are likely relevant to PSC. The USA patients demonstrated higher environmental chemical bile content and increased associations between chemicals and metabolic pathways than those in Norway. Polychlorinated biphenyl (PCB)-118 and PCB-101 were identified as chemicals of interest for additional investigation in PSC given broad associations with metabolomic pathways in both the USA and Norway patients. Associated pathways include glycan degradation pathways, which play a key role in microbiome regulation and thus may be implicated in PSC pathophysiology.
Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study
Millar, Peter R , Gordon, Brian A. , Luckett, Patrick H. , Fagan, Anne M. , Hassenstab, Jason , Perrin, Richard J. , Day, Gregory S. , Farlow, Martin R. , Mori, Hiroshi , Nübling, Georg, Network, The Dominantly Inherited Alzheimer, Bateman, Randall J. , Morris, John C. , Goate, Alison , Fox, Nick C. , Xiong, Chengjie , Gardener, Samantha L. , Vöglein, Jonathan , Wang, Qing , Xu, Jinbin , Ances, Beau M , Gordon, Brian A , Day, Gregory S , Bateman, Randall J , Vöglein, Jonathan , Xiong, Chengjie , Fox, Nick C , Hassenstab, Jason , Morris, John C , Goate, Alison M , Benzinger, Tammie L.S. , Cruchaga, Carlos , Schindler, Suzanne E. , Allegri, Ricardo , Nübling, Georg , Network, The Dominantly Inherited Alzheimer, Ances, Beau M.

Mayo Clinic

eLife | January 6, 2023 | Volume: 12 | Issue: No issue available | Pages: No page available

10.7554/elife.81869 | PMID 36607335 Get It

Background: Estimates of ‘brain-predicted age’ quantify apparent brain age compared to normative trajectories of neuroimaging features. The brain age gap (BAG) between predicted and chronological age is elevated in symptomatic Alzheimer disease (AD) but has not been well explored in presymptomatic AD. Prior studies have typically modeled BAG with structural MRI, but more recently other modalities, including functional connectivity (FC) and multimodal MRI, have been explored. Methods: We trained three models to predict age from FC, structural (S), or multimodal MRI (S+FC) in 390 amyloid-negative cognitively normal (CN/A−) participants (18–89 years old). In independent samples of 144 CN/A−, 154 CN/A+, and 154 cognitively impaired (CI; CDR > 0) participants, we tested relationships between BAG and AD biomarkers of amyloid and tau, as well as a global cognitive composite. Results: All models predicted age in the control training set, with the multimodal model outperforming the unimodal models. All three BAG estimates were significantly elevated in CI compared to controls. FC-BAG was significantly reduced in CN/A+ participants compared to CN/A−. In CI participants only, elevated S-BAG and S+FC BAG were associated with more advanced AD pathology and lower cognitive performance. Conclusions: Both FC-BAG and S-BAG are elevated in CI participants. However, FC and structural MRI also capture complementary signals. Specifically, FC-BAG may capture a unique biphasic response to presymptomatic AD pathology, while S-BAG may capture pathological progression and cognitive decline in the symptomatic stage. A multimodal age-prediction model improves sensitivity to healthy age differences. Funding: This work was supported by the National Institutes of Health (P01-AG026276, P01- AG03991, P30-AG066444, 5-R01-AG052550, 5-R01-AG057680, 1-R01-AG067505, 1S10RR022984-01A1, and U19-AG032438), the BrightFocus Foundation (A2022014F), and the Alzheimer’s Association (SG-20-690363-DIAN).
Creutzfeldt–Jakob Disease Misdiagnosed as Multiple System Atrophy
Martin, Nicholas B. , Koga, Shunsuke , Sekiya, Hiroaki , Dickson, Dennis W. , Dickson, Dennis W , Koga, Shunsuke , Sekiya, Hiroaki , Appleby, Brian S.

Mayo Clinic

Movement Disorders Clinical Practice | January 6, 2023 | Volume: 10 | Issue: 3 | Pages: 496-500

10.1002/mdc3.13654 | PMID 36949796 Get It

AbstractBackgroundMultiple system atrophy (MSA) is a progressive neurodegenerative disorder characterized by various combinations of autonomic failure, parkinsonism, and cerebellar syndromes. Although consensus criteria have been widely used to diagnose MSA, accurate clinical diagnosis remains challenging. Other neurodegenerative disorders, such as Lewy body disease, can mimic MSA.ObjectivesWe described clinical and neuropathologic findings of two patients with Creutzfeldt–Jakob disease (CJD) who had antemortem clinical diagnoses of MSA.MethodsThe brain bank for neurodegenerative disorders was queried for cases with a clinical diagnosis of MSA, but neuropathologic findings of CJD.ResultsCase 1 was a 55‐year‐old man with a 6‐month history of orthostatic hypotension, parkinsonism, cerebellar ataxia, bradyphrenia, and memory impairment. Case 2 was a 65‐year‐old man who had a 5‐year history of cerebellar ataxia, parkinsonism, and cognitive impairment, as well as a 7‐year history of dream enactment behavior. Neither case had characteristic α‐synuclein immunoreactive neuronal or glial inclusions typical of MSA. Instead, they had spongiform encephalopathy with neuronal loss and gliosis with prion protein‐immunoreactive kuru‐like plaques. Genetic analyses in case 1 had wild‐type PRNP, whereas case 2 revealed a 4‐octapeptide repeat insertion in PRNP.ConclusionsEven when clinical features suggest MSA, CJD should also be considered if the progression is rapid or the disease course is atypical, such as the absence of autonomic dysfunction for an extended period.
Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers
Kawakubo, Hirofumi , Kim, Hyoung‐Il , Nakao, Atsushi , Williams, Lori, Mendoza, Tito R. , Wang, Xuemei , Mansfield, Paul, Kitagawa, Yuko , Mendoza, Tito , Ikoma, Naruhiko , Grotz, Travis E. , Matsuda, Satoru , Hirata, Yuki , Williams, Lori, Wang, Xin , Badgwell, Brian D. , Hyung, Woo Jin

Mayo Clinic

No container title available | January 5, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1805561/v1 Get It

Abstract Background: The current standard operation for proximal gastric and gastroesophageal junction (P/GEJ) cancers with limited esophageal extension is total gastrectomy (TG). TG is associated with impaired appetite and weight loss, which is caused by a decreased level of ghrelin and anemia due to intrinsic factor loss and vitamin B12 malabsorption. Theoretically, proximal gastrectomy (PG) can mitigate these problems by preserving gastric function. However, PG with direct esophagogastric reconstruction is associated with severe postoperative reflux, delayed gastric emptying, and poor quality of life (QoL). Minimally invasive PG (MIPG) with antireflux techniques has been increasingly performed by experts but is technically demanding owing to its complexity. Moreover, the actual advantages of MIPG over minimally invasive TG (MITG) with regards to postoperative QoL are unknown. Our overall objective of this study is to determine the short-term QoL benefits of MIPG. Our central hypotheses are that MIPG is safe and that patients have improved appetite after MIPG with effective antireflux techniques, which leads to an overall QoL improvement when compared with MITG. Methods: Enrollment of a total of 60 patients in this prospective survey-collection study is expected. Procedures (MITG versus MIPG, antireflux techniques for MIPG [double-tract reconstruction versus the double-flap technique]) will be chosen based on surgeon and/or patient preference. Randomization is not considered feasible because patients often have strong preferences regarding MITG and MIPG. The primary outcome is appetite level (reported on a 0-10 scale) at 3 months after surgery. With an expected 30 patients per cohort (MITG versus MIPG), this study will have 80% power to detect a one-point difference in appetite level. Patient-reported outcomes will be longitudinally collected (including questions about appetite and reflux), and specific QoL items, body weight, body mass index and ghrelin, albumin, and hemoglobin levels will be compared. Discussion: Surgeons from the US, Japan, and South Korea formed this collaboration with the agreement that the surgical approach to P/GEJ cancers is an internationally important but controversial topic that requires immediate action. At the completion of the proposed research, our expected outcome is the establishment of the benefit and safety of MIPG. Trial Registration Number: This trial was registered with Clinical Trials Reporting Program Registration under the registration number NCI-2022-00267 on January 11, 2022, as well as with ClinicalTrials.gov under the registration number NCT05205343 on January 11, 2022.
The treatment of functional dyspepsia: present and future
Lacy, Brian E. , Chase, R. Christopher , Cangemi, David J. , Chase, R Christopher

Mayo Clinic

Expert Review of Gastroenterology & Hepatology | January 2, 2023 | Volume: 17 | Issue: 1 | Pages: 9-20

10.1080/17474124.2023.2162877 | PMID 36588474 Get It

Outcomes of patients with limited‐stage plasmablastic lymphoma: A multi‐institutional retrospective study
Hess, Brian , Giri, Anshu , Park, Yeonhee , Patel, Krina K. , Link, Brian K. , Nowakowski, Grzegorz S. , Maliske, Seth , Chávez, Julio C. , Hill, Brian T. , Garcia, Alex, Maddocks, Kami J. , Wagner‐Johnston, Nina D. , Messmer, Marcus R., Watkins, Marcus P. , Alderuccio, Juan Pablo , Lossos, Izidore S., Nathan, Sunita , Portell, Craig A. , Ayers, Emily C. , Fortin, Sonia, Chavez, Julio C , Watkins, Marcus , Alderuccio, Juan Pablo , De La Fuente, Macarena , Landsburg, Daniel J , Castillo, Jorge J , Link, Brian K , Portell, Craig A , Fortin, Sonia, Saeed, Hayder , Hanel, Walter G. , Messmer, Marcus , Kahl, Brad S. , Lossos, Izidore S. , Orellana‐Noia, Victor M. , Landsburg, Daniel J. , Castillo, Jorge J.

Mayo Clinic

American Journal of Hematology | January 2, 2023 | Volume: 98 | Issue: 2 | Pages: 300-308

10.1002/ajh.26784 | PMID 36588409 Get It

AbstractPlasmablastic lymphoma (PBL) is a rare entity, commonly associated with immunosuppressed states such as human immunodeficiency virus (HIV) infection or solid organ transplant. The clinical course is characterized by high relapse rates and a poor prognosis, leading some clinicians to recommend aggressive frontline therapy. However, a specific review of limited stage (LS) PBL patients is not available to evaluate outcomes and justify treatment recommendations. We performed a retrospective review of LS PBL cases to provide insight into this rare disease. Our cohort consisted of 80 stage I or II PBL patients from 13 US academic centers. With a median follow up of 34 months (1–196), the 3‐year progression‐free survival (PFS) and overall survival (OS) of the entire cohort were 72% (95% CI 62, 83) and 79% (95% CI 70, 89), respectively. The 3‐year PFS and OS of patients treated with frontline chemotherapy alone was 65% (95% CI 50, 84) and 71% (95% CI 56, 89), respectively, compared to 85% (95% CI 72, 100) and 96% (95% CI 89, 100), respectively, in patients treated with combined frontline chemotherapy with radiation consolidation. Our data demonstrate favorable outcomes in LS PBL with no improvements in outcome from aggressive frontline treatment including Hyper‐CVAD or auto‐SCT consolidation. Multivariate regression analysis (MRA) demonstrated improved PFS for patients receiving EPOCH based frontline therapy versus CHOP (HR: 0.23; p = 0.029). Frontline chemotherapy followed by radiation consolidation versus chemotherapy alone appeared to be associated with improved relapse and survival outcomes but did not show statistical significance in MRA.
Multisite ALLFTD study modeling progressive empathy loss from the earliest stages of behavioral variant frontotemporal dementia
Toller, Gianina , Callahan, Patrick , Brushaber, Danielle , Domoto‐Reilly, Kimiko , Forsberg, Leah K. , Ghoshal, Nupur , Graff‐Radford, Jonathan, Graff-Radford, N. R., Heuer, Hilary W. , Kornak, John , Kremers, Walter K. , Mackenzie, Ian R. , Pascual, María Belén, Ramos, Eliana Marisa , Rascovsky, Katya, Staffaroni, Adam M. , Tartaglia, Maria Carmela , Weıntraub, Sandra , Boxer, Adam L. , Rosen, Howard J. , Rankin, Katherine P. , Graff-Radford, Neil R, Boeve, Brad F, Tartaglia, Maria Carmela , Kremers, Walter K , Domoto-Reilly, Kimiko , Cobigo, Yann , Appleby, Brian S. , Graff‐Radford, Jonathan , Grossman, Murray , Lapid, Maria I. , Léger, Gabriel C. , Litvan, Irene , Rojas, Julio C. , Toga, Arthur W. , Wszołek, Zbigniew K. , Boeve, Bradley F.

Mayo Clinic

Alzheimer's & Dementia | January 2, 2023 | Volume: 19 | Issue: 7 | Pages: 2842-2852

10.1002/alz.12898 | PMID 36591730 Get It

AbstractIntroductionEmpathy relies on fronto‐cingular and temporal networks that are selectively vulnerable in behavioral variant frontotemporal dementia (bvFTD). This study modeled when in the disease process empathy changes begin, and how they progress.MethodsFour hundred thirty‐one individuals with asymptomatic genetic FTD (n = 114), genetic and sporadic bvFTD (n = 317), and 163 asymptomatic non‐carrier controls were enrolled. In sub‐samples, we investigated empathy measured by the informant‐based Interpersonal Reactivity Index (IRI) at each disease stage and over time (n = 91), and its correspondence to underlying atrophy (n = 51).ResultsEmpathic concern (estimate = 4.38, 95% confidence interval [CI] = 2.79, 5.97; p < 0.001) and perspective taking (estimate = 5.64, 95% CI = 3.81, 7.48; p < 0.001) scores declined between the asymptomatic and very mild symptomatic stages regardless of pathogenic variant status. More rapid loss of empathy corresponded with subcortical atrophy.DiscussionLoss of empathy is an early and progressive symptom of bvFTD that is measurable by IRI informant ratings and can be used to monitor behavior in neuropsychiatry practice and treatment trials.
Single-Cycle Adenoviruses (SC-Ads) as Platforms for Immunostimulation
Barry, Mary , Parrett, Brian J. , Zell, Brady N. , Barry, Michael A. , Barry, Mary, Lu, Shao‐Chia , Matchett, William E.

Mayo Clinic

The Journal of Immunology | January 1, 2023 | Volume: 204 | Issue: 1_Supplement | Pages: 166.30-166.30

10.4049/jimmunol.204.supp.166.30 Get It

Abstract Most adenovirus vaccines are replication-defective RD-Ads. In contrast, replication-competent adenovirus (RC-Ad) replicate antigen genes 10,000-fold in each cell to amplify immune responses. While RC-Ads vaccines are more potent than RD-Ad, they risk causing adenovirus infections in humans. We engineered “single-cycle” Ad (SC-Ad) vectors that still amplify transgenes, but that do not produce infectious progeny. RD-, SC-, and RC-Ads were tested by single immunization against influenza, Ebola virus, HIV-1, Zika virus, HCV, CMV, Clostridium difficile, and cancers in mice, hamsters, and macaques and antibody and T cell responses were measured. SC-Ad expressing GFP, influenza HA, or HIV gp140 generated antigens with 33 to 100-times less virus than RD-Ad. SC-Ad generated vaginal antibodies that persisted beyond 6 months after single intranasal immunization. Intramuscular injection of 1010 vp of SC-Ad6 expressing HIV-1 gp160 generated env antibodies in sera within 4 weeks of a single immunization in rhesus macaques. SC-Ad expressing a C. difficile toxin A and B immunogen generated toxin-binding antibody reciprocal titers above 105 that persisted in excess of a half of a year after a single immunization. Single immunization with SC-Ad protected vaccinated animals against toxin and against challenge with C. difficile spores. When SC-Ads were used to amplify the expression of immune stimulatory proteins in the context of cancer, single intratumoral injection of SC-Ad expressing 4-1BBL or GMCSF mediated significant reductions in tumor growth and extension of survival without the need for exogenous cancer antigen expression. These data suggest that SC-Ads may have utility against infectious diseases and cancer.
Eosinophil accumulation in postnatal lung is specific to the primary septation phase of development
Coden, Mackenzie E., Loffredo, Lucas F. , Jeong, Brian M., Walker, Matthew , Doan, Ton, Rodríguez, Raúl , Browning, M.C.K., Nam, Ki-Won , Lee, James , Berdnikovs, Sergejs , Anekalla, Kishore Reddy , Rodriguez, Raul, Browning, Mandy, Abdala‐Valencia, Hiam

Mayo Clinic

The Journal of Immunology | January 1, 2023 | Volume: 204 | Issue: 1_Supplement | Pages: 235.11-235.11

10.4049/jimmunol.204.supp.235.11 Get It

Abstract Type 2 immune cells and eosinophils are transiently present in lung tissue not only in pathology but also during normal postnatal development. However, the lung developmental processes underlying postnatal airway recruitment of eosinophils after birth remain unexplored. We determined that in mice, mature eosinophils are recruited to the lung during P3–14, which corresponds to the primary septation/alveolarization phase of lung development. Developmental eosinophils peaked during P10–14 and exhibited Siglec-Fmed/highCD11c−/low phenotypes, similar to allergic asthma models. By interrogating the lung transcriptome and proteome during peak eosinophil recruitment in postnatal development, we identified markers that functionally capture mesenchymal-epithelial interface establishment (Nes, Smo, Wnt5a, Nog) and provisional extracellular matrix (ECM) deposition (Tnc, Postn, Spon2, Thbs2) as key lung morphogenetic events associating with eosinophils. We identifiedTenascin-C (TNC) as one of the key ECM markers in the lung epithelial-mesenchymal interface at the RNA and protein levels, consistently associating with eosinophils in development and disease. By RNA-seq analysis, naïve murine eosinophils cultured with TNC-enriched ECM significantly induced expression of Siglec-F, CD11c, eosinophil peroxidase, and other markers typical for activated eosinophils in development and allergic inflammatory responses. TNC knockout mice had an altered eosinophil recruitment profile in development. Collectively, our results indicate that lung morphogenetic processes associated with heightened Type 2 immunity are not merely tissue “background” but specifically guide immune cells both in development and pathology.